Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP block for congenital hip dislocation surgery
NCT03949686Completed
- Sponsor
- Atatürk University
- Start
- Apr 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in developmental dysplasia of the hip (DDH) (2 arms), sponsored by Atatürk University. Primary endpoint: Face, Legs, Activity, Cry and Consolability at 24 hours. Started Apr 2019; status: completed.
02
Drugs
bupivacaine
03
Conditions
developmental dysplasia of the hip (DDH)
Beyond the preview
Go deeper on NCT03949686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03949686.